GenIC Clearance for CDC/ATSDR
Formative Research and Tool Development
OMB Control No. 0920-1154
Expiration Date: 03/31/2026
CDC OneLab Formative Evaluation
Contact: Amber Eberhardt
Health Scientist/Program Evaluator, TWDB
Division of Laboratory Systems
Centers for Disease Control and Prevention
1600 Clifton Road, NE
Atlanta, Georgia 30333
Phone: (571) 484-8131
Email: oev8@cdc.gov
B. Collections of Information Employing Statistical Methods 2
B.1. Respondent Universe and Sampling Methods 2
B.2. Procedures for the Collection of Information 3
B.3. Methods to maximize Response Rates and Deal with No Response 3
B.4. Tests of Procedures or Methods to be undertaken 4
B.5. Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data 4
Attachment 1: OneLab Key Informant Semi-Structured Interview 4
Attachment 2: OneLab Focus Group Discussion 4
Attachment 3: Emails for OneLab Qualitative Evaluation participants 4
Attachment 4: Participant Intake Form 4
Attachment 5: Focus Group Consent Form 4
Attachment 6: Human Subjects Research Determination 4
The collection does not involve statistical methods and the purpose of the collection is not to make statistical generalizations beyond the particular respondents.
For the CDC OneLab Qualitative data collection, the Data and Evaluation project team will be recruiting participants based on their level of involvement in CDC OneLab and the five out of seven OneLab elements (i.e., OneLab REACH, OneLab Network, OneLab TEST, OneLab VR, and OneLab Summit). The inclusion and exclusion criteria will vary based on the group of interest. All participants will be asked about their overall experience as it relates to the initiative as a whole.
For OneLab REACH and OneLab VR, the project team will utilize the OneLab REACH course completion list to identify participants. Specifically, for OneLab Network, OneLab TEST, and OneLab Summit, the project team will utilize registration, and attendance lists from the most recent OneLab event to identify the participants. At least 25% of participants will be recruited from resource-limited areas. Additional inclusion criteria to select participants for all of the elements can be found in their respective sections below:
OneLab REACH and VR inclusion criteria
OneLab REACH
All participants have to complete at least three courses for the past six months.
Participants need to be identified as active user of OneLab REACH for the past six months.
Must be a laboratory or testing working professional.
OneLab VR
All recruited participants need to complete at least one or two OneLab VR scenarios/micro-learning courses.
Or Participants need to engage at least 30 minutes in OneLab VR open play for the past six months.
Must be a laboratory or testing working professional.
OneLab Network and TEST inclusion criteria
All participants must attend at least one event in the last three months.
Must be a laboratory or testing working professional.
OneLab Summit inclusion criteria
All participants must have attended the most recent OneLab Summit.
Must be a laboratory or testing working professional.
The Data and Evaluation team will select 25 key informant interview and another 25 focus group participants from the OneLab user lists who meet the study eligible criteria. Upon identified participants, the project team will send them an initial study invitation email to explain the purpose of the study and ask for their willingness and availability to join the study. Confirmed participants will also receive 2-3 follow-up email reminders to join the scheduled focus group or key informant interviews.
Project results from this survey will be reported publicly in anonymized, aggregated summary form (i.e. summary report) to inform CDC and other public health and clinical laboratory partners. Identifying information for responding laboratories and organizations will not be released to the public. Data collected and generated by this evaluation will be transferred and stored to CDC internal servers. All data will be deidentified. Access to survey data will be limited to authorized users and will be password protected in order to promote data security and compliance.
The Data and Evaluation team will first conduct research on participants’ available and preferred meeting time. The project team will then send 2-3 follow-up emails and meeting reminders to encourage participants to join the key informant interviews and focus group interviews.
Both the key informant interview guide and focus group interview guide will be pilot-tested among staff in the Data and Evaluation team.
No individuals were consulted on statistical aspects of the design. The individuals collecting and/or analyzing data include:
Lead Investigator: Amber Eberhardt, Health Scientist/ Program Evaluator, Center for Laboratory Systems and Response, Division of Laboratory Systems (DLS), Centers for Disease Control and Prevention (CDC)
Co-Investigators:
Breyanna Mikel, Health Scientist/ Program Evaluator, Center for Laboratory Systems and Response Division of Laboratory Systems (DLS), Centers for Disease Control and Prevention (CDC)
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| Author | Samuel, Lee (CDC/OID/NCEZID) |
| File Modified | 0000-00-00 |
| File Created | 2025-07-01 |